deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT04597918

A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab (ALTIMETER)

An Exploratory, Prospective, Multi-Center, Open-Label, Single-Arm, Interventional, Phase IIB Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Patients With Diabetic Macular Edema Treated With Faricimab (RO6867461) - ALTIMETER STUDY

Sponsor: Hoffmann-La Roche

Conditions Diabetic Macular Edema
Interventions Faricimab
Updated 27 times since 2020 Last updated: Nov 10, 2023 Started: Nov 25, 2020 Primary completion: Dec 22, 2022 Completion: Dec 22, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Diabetic Macular Edema, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 27 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Nov 2023 · 10 months · monthly snapshot~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

27 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2024 — Jul 2024 [monthly]

    Completed PHASE2

  5. Nov 2023 — Jan 2024 [monthly]

    Completed PHASE2

▶ Show 22 earlier versions

  1. Jan 2023 — Nov 2023 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Dec 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Nov 2022 — Dec 2022 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  6. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  7. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  8. Mar 2022 — May 2022 [monthly]

    Recruiting PHASE2

  9. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  10. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE2

  11. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  12. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  13. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  14. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  15. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  16. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  17. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  18. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  19. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  20. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  21. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  22. Nov 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hoffmann-La Roche
Data source: Hoffmann-La Roche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abilene, United States , Austin, United States , Capital Federal, Argentina , Chicago, United States , Etobicoke, Canada , Germantown, United States , Gloucestershire, United Kingdom , Hagerstown, United States , Hauppauge, United States , Indianapolis, United States and 11 more locations